UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (3), p.398-406

2014

Volltextzugriff (PDF)

Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.381-388

2016

Volltextzugriff (PDF)

Clinical experience with moroctocog alfa (AF‐CC) in younger paediatric patients with severe haemophilia A: Two open‐label studies

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.604-610

2018

Volltextzugriff (PDF)

Lack of seasonal variation in bleeding and patient-assessed pain patterns in patients with haemophilia B receiving on-demand therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (3), p.349-353

2014

Volltextzugriff (PDF)

Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (5), p.e374-e378

2012

Volltextzugriff (PDF)

A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-07, Vol.18 (4), p.503-509

2012

Volltextzugriff (PDF)

Decline of high hepatitis C virus prevalence in a hemodialysis unit with no isolation measures during a 6-year follow-up

Clinical nephrology, 2002-05, Vol.57 (5), p.371-375

2002

Volltextzugriff (PDF)

Massive plasmocytosis due to methimazole‐induced bone marrow toxicity

American journal of hematology, 2001-08, Vol.67 (4), p.259-261

2001

Volltextzugriff (PDF)

Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies

Journal of blood medicine, 2020-01, Vol.11, p.439-448

2020

Volltextzugriff (PDF)

The role of transfusion-transmitted virus in patients undergoing hemodialysis

Journal of clinical gastroenterology, 2002-01, Vol.34 (1), p.86-88

2002

Volltextzugriff (PDF)

Plasma erythropoietin levels in the oldest old

International urology and nephrology, 2004, Vol.36 (2), p.259-262

2004

Volltextzugriff (PDF)

Evidence of hepatitis C virus passage across dialysis membrane

Nephron (2015), 1998-10, Vol.80 (2), p.194-196

1998

Volltextzugriff (PDF)

Influence of Hemodialysis Procedure on HCV RNA Detection in Serum and Peripheral Blood Mononuclear Cells

Renal failure, 2004-01, Vol.26 (4), p.369-373

2004

Volltextzugriff (PDF)

Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial

Pediatrics (Evanston), 2000-05, Vol.105 (5), p.1066-1072

2000

Volltextzugriff (PDF)

Erythropoietin and preemies

Pediatrics (Evanston), 2002-12, Vol.110 (6), p.1253

2002

Volltextzugriff (PDF)

A double-blind controlled trial of recombinant interferon-α2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels

Journal of viral hepatitis, 1997-03, Vol.4 (2), p.113-119

1997

Volltextzugriff (PDF)

Alpha-interferon therapy induces improvement of platelet counts in children with chronic idiopathic thrombocytopenic purpura

Journal of pediatric hematology/oncology, 2001-12, Vol.23 (9), p.598-603

2001

Volltextzugriff (PDF)

A double-blind controlled trial of recombinant interferon- alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels

Journal of viral hepatitis, 1997-03, Vol.4 (2), p.113-119

1997

Volltextzugriff (PDF)

Hepatitis G Virus Infection in Hemodialysis Patients and Its Relationship with Hepatitis C Virus Infection

American journal of nephrology, 2000-09, Vol.20 (5), p.380-384

2000

Volltextzugriff (PDF)

CHANGES ON BODY GROWTH AND EFFECT OF RECOMBINANT HUMAN ERYTHROPOIETIN (rHU EPO). TREATMENT ON RENAL ANEMIA OF CHILDREN WITH END STAGE RENAL DESEASE(ERSD)

Pediatric research, 1997-01, Vol.41 (1), p.157-157

1997

Volltextzugriff (PDF)

Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up

The international journal of tuberculosis and lung disease, 1999-03, Vol.3 (3), p.214

1999

Volltextzugriff (PDF)

A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection

Journal of viral hepatitis, 1997-03, Vol.4 (2), p.113

1997

Volltextzugriff (PDF)

Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer

Medicina (Buenos Aires), 2002, Vol.62 (1), p.41

2002

Volltextzugriff (PDF)

Hepatitis C virus RNA and long-term response to recombinant interferon-α2b in patients with chronic hepatitis C

Journal of viral hepatitis, 1995-03, Vol.2 (2), p.97-102

1995

Volltextzugriff (PDF)

Hepatitis C virus RNA and long-term response to recombinant interferon-alpha 2b in patients with chronic hepatitis C

Journal of viral hepatitis, 1995, Vol.2 (2), p.97-102

1995

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(94)
Bücher
(2)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects

Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B

Clinical experience with moroctocog alfa (AF‐CC) in younger paediatric patients with severe haemophilia A: Two open‐label studies

Lack of seasonal variation in bleeding and patient-assessed pain patterns in patients with haemophilia B receiving on-demand therapy

Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B

A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use

Decline of high hepatitis C virus prevalence in a hemodialysis unit with no isolation measures during a 6-year follow-up

Massive plasmocytosis due to methimazole‐induced bone marrow toxicity

Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies

The role of transfusion-transmitted virus in patients undergoing hemodialysis

Plasma erythropoietin levels in the oldest old

Evidence of hepatitis C virus passage across dialysis membrane

Influence of Hemodialysis Procedure on HCV RNA Detection in Serum and Peripheral Blood Mononuclear Cells

Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial

Erythropoietin and preemies

A double-blind controlled trial of recombinant interferon-α2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels

Alpha-interferon therapy induces improvement of platelet counts in children with chronic idiopathic thrombocytopenic purpura

A double-blind controlled trial of recombinant interferon- alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels

Hepatitis G Virus Infection in Hemodialysis Patients and Its Relationship with Hepatitis C Virus Infection

CHANGES ON BODY GROWTH AND EFFECT OF RECOMBINANT HUMAN ERYTHROPOIETIN (rHU EPO). TREATMENT ON RENAL ANEMIA OF CHILDREN WITH END STAGE RENAL DESEASE(ERSD)

Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up

A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection

Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer

Hepatitis C virus RNA and long-term response to recombinant interferon-α2b in patients with chronic hepatitis C

Hepatitis C virus RNA and long-term response to recombinant interferon-alpha 2b in patients with chronic hepatitis C

Suchergebnisse filtern